We are live on ! Find out more
COCH icon

Envoy Medical
COCH

94 hedge funds and large institutions have $362M invested in Envoy Medical in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

229% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 7

56% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 9

9% more capital invested

Capital invested by funds: $331M → $362M (+$30.8M)

6.7% more ownership

Funds ownership: 80.61% → 87.31% (+6.7%)

6% more funds holding

Funds holding: 89 → 94 (+5)

Holders
94
Holders Change
+5
Holders Change %
+5.62%
% of All Funds
1.62%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
14
Increased
23
Reduced
7
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$11.1M
2
MF
Magnetar Financial
Illinois
+$10.7M
3
Millennium Management
Millennium Management
New York
+$6.72M
4
DCM
Difesa Capital Management
New York
+$3.08M
5
HCM
Highbridge Capital Management
New York
+$2.95M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$9.06M
2
HI
HBK Investments
Texas
-$7.5M
3
Parallax Volatility Advisers
Parallax Volatility Advisers
California
-$3.52M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$2.94M
5
PMAM
Picton Mahoney Asset Management
Ontario, Canada
-$2.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
76
Basso Capital Management
Connecticut
$407K – – –
WMSA
77
Weiss Multi-Strategy Advisers
New York
$378K – – –
RCM
78
Robinson Capital Management
Michigan
$360K +$118K +12,000 +49%
OFG
79
OTA Financial Group
New York
$356K +$134K +13,598 +60%
LCM
80
Landscape Capital Management
New Jersey
$295K +$171K +17,439 +139%
Parallax Volatility Advisers
81
Parallax Volatility Advisers
California
$262K -$3.52M -358,595 -93%
E
82
Ergoteles
New York
$260K +$259K +26,400 New
TI
83
Tidal Investments
Wisconsin
$242K – – –
JP Morgan Chase
84
JP Morgan Chase
New York
$236K -$757K -77,079 -76%
MIG
85
Mariner Investment Group
New York
$196K – – –
Geode Capital Management
86
Geode Capital Management
Massachusetts
$187K +$54.8K +5,582 +41%
DFCM
87
Dark Forest Capital Management
Puerto Rico
$156K +$124K +12,625 +393%
SSA
88
Schonfeld Strategic Advisors
New York
$130K – – –
Walleye Capital
89
Walleye Capital
New York
$122K – – –
EC
90
Elequin Capital
New York
$15K +$14.7K +1,500 New
Bank of America
91
Bank of America
North Carolina
$10K -$1.42M -144,239 -99%
CS
92
Clear Street
New York
$7K +$6.89K +702 New
UBS Group
93
UBS Group
Switzerland
$4K -$5.67K -577 -61%
Bank of Montreal
94
Bank of Montreal
Ontario, Canada
$287 +$40.8K +4,150 +17%
HI
95
HBK Investments
Texas
– -$7.5M -764,759 Closed
Alyeska Investment Group
96
Alyeska Investment Group
Illinois
– -$2.94M -300,000 Closed
PMAM
97
Picton Mahoney Asset Management
Ontario, Canada
– -$2.94M -299,994 Closed
6CM
98
683 Capital Management
New York
– -$1.47M -150,000 Closed
TCM
99
Tegean Capital Management
New York
– -$686K -70,000 Closed
KCM
100
Kawa Capital Management
Florida
– -$554K -56,522 Closed
1 2 3
4
5

COCH Hedge Fund Activity: Q3 2022 in Review

94 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q3 2022, worth a combined $362M — up 9.3% from $331M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new COCH positions and 9 closed out — a net gain of 5 holders — while 23 added to existing stakes and 7 trimmed.

The largest buyer was BNP Paribas Financial Markets, opening a new position worth an estimated $11.1M. The largest seller was Goldman Sachs, cutting an estimated $9.06M.

  • 94 institutional investors held Envoy Medical (COCH) as of Q3 2022, up from 89 in Q2 2022.
  • Funds reported $362M of Envoy Medical stock for Q3 2022, up 9.3% quarter-over-quarter.
  • 14 funds opened new Envoy Medical positions in Q3 2022 and 9 closed out, a net change of +5 holders.
  • The largest Envoy Medical buyer in Q3 2022 was BNP Paribas Financial Markets, an estimated $11.1M added.
  • The largest Envoy Medical seller in Q3 2022 was Goldman Sachs, an estimated $9.06M sold.

Based on aggregated 13F filings for Q3 2022.